<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To determine which of two treatments for reducing ischemic injury after temporal focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is more effective, the effects of mild (33 degrees C) intraischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> were compared with those of <z:chebi fb="1" ids="29864">mannitol</z:chebi>, the most commonly used neuroprotective agent </plain></SENT>
<SENT sid="1" pm="."><plain>Four groups of Sprague-Dawley rats underwent 1 hour of endovascular middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> followed by 23 hours of normothermic reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>The four experimental groups were as follows: Group A, saline control; Group B, <z:chebi fb="1" ids="29864">mannitol</z:chebi> (25%, 1 g/kg); Group C, <z:hpo ids='HP_0002045'>hypothermia</z:hpo>; and Group D, <z:hpo ids='HP_0002045'>hypothermia</z:hpo> plus man-nitol </plain></SENT>
<SENT sid="3" pm="."><plain>Laser-Doppler estimates of cortical blood flow showed that <z:hpo ids='HP_0002045'>hypothermia</z:hpo> did not affect blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> or reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="1" ids="29864">Mannitol</z:chebi> increased cortical blood flow during <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion under both normothermic and hypothermic conditions (p &lt; 0.05) </plain></SENT>
<SENT sid="5" pm="."><plain>Neurological deficit was significantly less severe in treated rats (Group B, p &lt; 0.05; Group C or D, p &lt; 0.01) than in controls (Group A) </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume, measured on semiserial Nissl-stained sections, was significantly smaller in treated rats (p &lt; 0.01) than in controls </plain></SENT>
<SENT sid="7" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was also significantly smaller in rats treated with <z:hpo ids='HP_0002045'>hypothermia</z:hpo> than in those treated with <z:chebi fb="1" ids="29864">mannitol</z:chebi> (Group C vs. Group B, p &lt; 0.05); there was no difference between rats treated with <z:chebi fb="1" ids="29864">mannitol</z:chebi> and those treated with <z:chebi fb="1" ids="29864">mannitol</z:chebi> and <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three treatments reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> area in the ischemic penumbra; <z:hpo ids='HP_0002045'>hypothermia</z:hpo> with or without <z:chebi fb="1" ids="29864">mannitol</z:chebi> also reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> area in the ischemic core </plain></SENT>
<SENT sid="9" pm="."><plain>These results demonstrate that both mild intraischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and <z:chebi fb="1" ids="29864">mannitol</z:chebi> reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> size and neurological deficit: <z:hpo ids='HP_0002045'>hypothermia</z:hpo> reduces <z:mpath ids='MPATH_124'>infarct</z:mpath> size more effectively than <z:chebi fb="1" ids="29864">mannitol</z:chebi>, and <z:chebi fb="1" ids="29864">mannitol</z:chebi> adds no significant protection to <z:hpo ids='HP_0002045'>hypothermia</z:hpo>, whereas <z:hpo ids='HP_0002045'>hypothermia</z:hpo> adds significant protection beyond that afforded by <z:chebi fb="1" ids="29864">mannitol</z:chebi> after brief focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by reperfusion in rats </plain></SENT>
<SENT sid="10" pm="."><plain>The results suggest that mild intraischemic <z:hpo ids='HP_0002045'>hypothermia</z:hpo> alone, or in combination with <z:chebi fb="1" ids="29864">mannitol</z:chebi>, may be useful in avoiding ischemic injury from temporary vessel occlusion during cerebrovascular surgery </plain></SENT>
</text></document>